Psoriasis Withdrawn Phase 2 Trials for Ciclosporin (DB00091)

Also known as: Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00377325The Effectiveness of Lower Cyclosporine Doses for PsoriasisTreatment